SonoVue (Sulphur hexafluoride microbubbles) is a microbubbles preparation that is stable, resistant to pressure and specifically designed to be used as a contrast agent for ultrasound imaging.
Study design : one contrast-enhanced ultrasonography is proposed before any surgery to patients with ovarian mass.
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
18 years of age or older
Patient with adnexal mass detected by ultrasound
Any programmed surgery
You may not be if
Any contraindication to surgery
Injection of another contrast agent within 24 hours before the study examination
Pregnancy, breastfeeding
Patient known to have a coronary syndrome
Unstable angina and myocardial infarction
Acute cardiac failure, Class III/IV cardiac failure
Severe rhythm disorders
Acute endocarditis
Prosthetic valves
Patient previously having received an investigational drug within 30 days prior to admission into this study
